NKGen Biotech Inc (NASDAQ:NKGN) price on Thursday, December 26, rose 11.12% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.87.
A look at the stock’s price movement, the close in the last trading session was $0.79, moving within a range at $0.781 and $0.96. The beta value (5-Year monthly) was 0.524. Turning to its 52-week performance, $4.06 and $0.20 were the 52-week high and 52-week low respectively. Overall, NKGN moved 140.53% over the past month.
NKGen Biotech Inc’s market cap currently stands at around $31.05 million, with investors looking forward to this quarter’s earnings report slated for in January.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NKGN is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
NKGN’s current price about 66.13% and 113.87% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 80.86, while 7-day volatility ratio is 21.00% and 17.87% in the 30-day chart. Further, NKGen Biotech Inc (NKGN) has a beta value of 0.68, and an average true range (ATR) of 0.09.
If we refocus on NKGen Biotech Inc (NASDAQ:NKGN), historical trading data shows that trading volumes averaged 0.39 over the past 10 days and 1.36 million over the past 3 months. The company’s latest data on shares outstanding shows there are 25.77 million shares.
The 48.77% of NKGen Biotech Inc’s shares are in the hands of company insiders while institutional holders own 10.57% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.87 million on 2024-11-29, giving us a short ratio of 0.9. The data shows that as of 2024-11-29 short interest in NKGen Biotech Inc (NKGN) stood at 868.0 of shares outstanding, with shares short rising to 0.71 million registered in 2024-10-31. Current price change has pushed the stock -68.21% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NKGN stock continues to rise going into the next quarter.
